Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC]

1781 reported adverse events

Drugs of this class: BACILLUS CALMETTE-GUERIN

These side effects are most commonly reported by patients taking drugs of the Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC] class:

# Side effect Count
0 NO ADVERSE EVENT 378
1 PRODUCT AVAILABILITY ISSUE 236
2 BLADDER CANCER RECURRENT 187
3 PRODUCT DOSE OMISSION 177
4 PRODUCT DOSE OMISSION ISSUE 107
5 DRUG INEFFECTIVE 88
6 PYREXIA 83
7 DISSEMINATED BACILLUS CALMETTE-GUERIN INFECTION 72
8 THERAPY NON-RESPONDER 72
9 PRODUCT SUPPLY ISSUE 67
See all common reactions for Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC]

Drugs of the Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CANCER CELLS URINE PRESENT 3 0.5000
1 HIGH INTENSITY FOCUSED ULTRASOUND 1 0.3333
2 BLADDER GRANULOMA 4 0.3333
3 BCG RELATED CYSTITIS 6 0.3000
4 BLADDER CANCER RECURRENT 187 0.1876
5 RADICAL CYSTECTOMY 6 0.1714
6 MANUFACTURING STABILITY TESTING ISSUE 1 0.1667
7 DISSEMINATED BACILLUS CALMETTE-GUERIN INFECTION 72 0.1542
8 CYSTITIS EROSIVE 1 0.1429
9 KOEPPE NODULES 1 0.1250
See all enriched reactions for Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC]